HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
FULLER & THALER ASSET MANAGEMENT, INC. 338,002$12,191,7220.07%
Epoch Investment Partners, Inc. 331,934$11,972,8590.07%
USA FINANCIAL FORMULAS 1,226$44,2220.07%
EFG Asset Management (Americas) Corp. 8,009$288,8850.07%
EFG CAPITAL INTERNATIONAL CORP. 8,009$288,8850.07%
Verdence Capital Advisors LLC 14,624$527,4880.06%
Ameritas Investment Partners, Inc. 43,912$1,583,9060.06%
AMERICAN INTERNATIONAL GROUP, INC. 261,720$9,440,2400.06%
LAZARD ASSET MANAGEMENT LLC 1,198,667$43,2350.05%
NorthCrest Asset Manangement, LLC 36,824$1,328,2420.05%
Coastal Bridge Advisors, LLC 6,000$216,4200.05%
GREAT LAKES ADVISORS, LLC 145,353$5,242,8800.05%
SIT INVESTMENT ASSOCIATES INC 53,775$1,9400.05%
Rafferty Asset Management, LLC 244,545$8,820,7380.05%
CARY STREET PARTNERS INVESTMENT ADVISORY LLC 20,338$733,5920.05%
First Trust Direct Indexing L.P. 11,371$410,1610.05%
Brookstone Capital Management 60,415$2,212,3970.04%
NEW MEXICO EDUCATIONAL RETIREMENT BOARD 27,600$9960.04%
NEW YORK STATE COMMON RETIREMENT FUND 949,387$34,2440.04%
Assenagon Asset Management S.A. 341,764$12,327,4270.04%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.